Dr Gary Newton’s team designs and synthesises molecules that inhibit key pathways in the development and progression of cancer with the aim of developing new, safer and more effective treatments
Dr Gary Newton is a member of the Cancer Research UK Cancer Therapeutics Unit where he applies his medicinal chemistry experience to validate new targets and develop effective medicines for the treatment of cancer. He has worked in biotech and contract research organisations over the course of 20 years, leading teams to discover a number of pre-clinical candidates.
I work as a medicinal chemist to design, synthesise, isolate and characterise novel compounds for the purpose of discovering a new drug, or elucidating a biological pathway. My current project focusses on utilising the body’s own immune system to fight cancer.